Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
 
Register | Sign in
Home Page > Videos > Precise, high-pressure programmable syringe pump / infusion pump
  Videos

Return

Precise, high-pressure programmable syringe pump / infusion pump
LAMBDA Laboratory Instruments

The LAMBDA VIT-FIT and VIT-FIT HP high-pressure syringe pumps are precise, polyvalent and programmable syringe/infusion pumps with an excellent price to performance ratio. The new syringe fixing system allows almost any type of syringes (plastic, glass or metal syringes) to be used, from micro syringes to large volume syringes. The syringe is tightly held in both directions – infusion and filling. These syringe pumps offer an unprecedented mechanical robustness and provide high forces of up to 600 N! The VIT-FIT syringe (infusion) pumps can be programmed for withdrawal and filling (dispensing) and can also be controlled remotely by analog or digital signals. The powerful mechanics of the LAMBDA VIT-FIT syringe pumps is fully protected and is therefore not damaged by accidental spills and syringe leakages. Discover more about the powerful syringe pumps on: http://www.syringepump.info/

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Accelerating Spirocyclic Polyketide Synthesis
Powerful flow chemistry techniques used for complex multi-stage synthesis of spirocyclic polyketides.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
First Atlas of Body Clock Gene Expression in Mammals Informs Timing of Drug Delivery
Penn Medicine study has implications for 100 top-selling US drugs, half of which target daily-oscillating genes.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Blood Test Developed to Diagnose Early Onset Alzheimer’s Disease
New blood-test could predict a person’s risk of developing AD much earlier than is currently possible.
Tea and Citrus Products Could Lower Ovarian Cancer Risk
New UEA research finds that women who consume foods containing flavonols and flavanones significantly decrease their risk of developing epithelial ovarian cancer.
TxCell Achieves Positive Results for Col-Treg in a Model of Autoimmune Uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic candidate in this rare eye disease.
Heart Drug May Help Treat ALS, Mouse Study Shows
Scientists blocked the enzyme in ALS astrocytes using digoxin, a medication used in the treatment of heart failure.
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.
LLNL, UC Davis Partner to Personalize Cancer Medications
With a $7.8 million, five-year grant from the NIH researchers are utilizing accelerator mass spectrometry for cancer research.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv